Skip to content
★ Sign in to follow
PC

Polar Capital Global Healthcare Trust plc Stock: price and insider trades · United Kingdom

ISIN GB00B6832P16GB·Mcap £466.3MBanks

No insider purchase over the last 90 days. The latest, by Stacey Parrinder-Johnson, was filed 11 Jun 2026.

Polar Capital Global Healthcare Trust plc: what insiders have been doing

This page follows insider dealings at Polar Capital Global Healthcare Trust plc as filed with RNS (LSE), a company from the Banks sector. 3 insiders have disclosed 3 filings since 22 October 2025.

The flow runs one way only: 3 insiders bought (3 purchases totalling €74k) and nobody sold on the market. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Caroline Gulliver filed the largest purchase, €48k, on 4 December 2025. Among those who bought: 3 board members.

With 3 filings in twelve months, the company is quieter than the median of 6 filings across the 832 companies we follow on the same exchange. Over the whole record (from 2017), the tally stands at 14 purchases and no sales.

The last insider purchase was made public on 11 June 2026, 150 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for notifying a trade is three business days (UK MAR).

These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.

Insider Decl.
14
Thresholds
n/a
Buy Volume
€372,107
14 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Stacey Parrinder-Johnson2 buys
Caroline Gulliver1 buy
Jeremy Whitley1 buy

Since the insiders bought

  • Filed 28 Sept 2020 · 2232 days ago · €25k
    +28.8%
    Entry £2.29 · Close at T+365 £2.95
  • Filed 23 Jul 2020 · 2299 days ago · €28k
    +12.0%
    Entry £2.46 · Close at T+365 £2.76
  • Filed 12 Mar 2020 · 2432 days ago · €23k
    +24.1%
    Entry £1.93 · Close at T+365 £2.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended September 2025 · cache

£4.32
Analyst consensus
·
Income statement
Revenue-£26.7M
Net income-£28.1M0.0% margin
Valuation
PER (trailing)10.3x
Balance sheet & cash
Market cap£466.3M
Total debt£1k
Free Cash Flow£10.8M
Profitability & ownership
% insiders0.5%
% institutions59.9%
Last declaration on 11 June 2026
Declarations14 total
  • ▲
    Non-executive DirectorExecutives
    21,999 GBP15RNS
    5,250 shares@ £4.1902100.0% of flowLondon Stock Exchange (XLON)RNS:763462c8-c165-45ab-b694-aff655b3e985
    Canonical exit: 9 Sept 2026 (T+90)
  • ▲
    Non-executive DirectorExecutives
    0RNS
    0London Stock Exchange (XLON)ISIN GB00B6832P16RNS:9614105
    Canonical exit: 9 Sept 2026 (T+90)
  • ▲
    Non-executive DirectorExecutives
    42,287 GBP15RNS
    10,000 shares@ £4.2287100.0% of flowLondon Stock Exchange (XLON)RNS:36c61f74-7eac-461f-9118-63ef71cf4be2
    Canonical exit: 2 Mar 2026 (T+90)
  • ▲
    Non-executive DirectorExecutives
    66,456 GBP15RNS
    20,000 shares@ £3.3228100.0% of flowLondon Stock Exchange (XLON)RNS:5735443
    Canonical exit: 9 Oct 2025 (T+90)
  • ▲
    Non-executive DirectorExecutives
    23,466 GBP15FCA-NSM
    10,000 shares@ £2.3466100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B6832P16FCA-NSM:3729985
    Canonical exit: 13 Dec 2020 (T+90)
  • ▲
    Non-executive DirectorExecutives
    25,470 GBP10FCA-NSM
    10,000 shares@ £2.54726.6% of flowLondon Stock Exchange (XLON)ISIN GB00B6832P16FCA-NSM:3665616
    Canonical exit: 21 Oct 2020 (T+90)
  • ▲
    Non-executive DirectorExecutives
    18,295 GBP21FCA-NSM
    10,000 shares@ £1.829516.0% of flowLondon Stock Exchange (XLON)ISIN GB00B6832P16FCA-NSM:LSE20200325160150_3541410_20200402123328054
    Canonical exit: 23 Jun 2020 (T+90)
  • ▲
    Non-executive DirectorExecutives
    19,917 GBP15FCA-NSM
    10,000 shares@ £1.9917100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B6832P16FCA-NSM:LSE20200312101003_3524437_20200331164956892_12913
    Canonical exit: 10 Jun 2020 (T+90)
  • ▲
    Non-executive DirectorExecutives
    20,165 GBP24FCA-NSM
    10,000 shares@ £2.016550.4% of flowLondon Stock Exchange (XLON)ISIN GB00B6832P16FCA-NSM:LSE20180605150209_13667893_20200330111424285_23626
    Canonical exit: 3 Sept 2018 (T+90)
  • ▲
    Non-executive DirectorExecutives
    20,165 GBP15FCA-NSM
    10,000 shares@ £2.0165100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B6832P16FCA-NSM:LSE20180605142234_13667819_20200330111424287_23672
    Canonical exit: 3 Sept 2018 (T+90)
  • ▲
    Non-executive DirectorExecutives
    19,360 GBP15FCA-NSM
    10,073 shares@ £1.922100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B6832P16FCA-NSM:LSE20180307113607_13558132_20200330111427854_24733
    Canonical exit: 5 Jun 2018 (T+90)
  • ▲
    Non-executive DirectorExecutives
    12,591 GBP30FCA-NSM
    5,889 shares@ £2.138100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B6832P16FCA-NSM:LSE20170620170855_13267264_20200330131522580_16176-0
    Canonical exit: 14 Sept 2017 (T+90)
  • ▲
    Non-executive DirectorExecutives
    25,184 GBP30FCA-NSM
    11,779 shares@ £2.138100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B6832P16FCA-NSM:LSE20170620170855_13267264_20200330131522580_16176-1
    Canonical exit: 14 Sept 2017 (T+90)
  • ▲
    Non-executive DirectorExecutives
    12,591 GBP30FCA-NSM
    5,889 shares@ £2.138100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B6832P16FCA-NSM:LSE20170620170855_13267264_20200330131522580_16176-2
    Canonical exit: 14 Sept 2017 (T+90)

14 of 14 declarations

About Polar Capital Global Healthcare Trust plc

Polar Capital Global Healthcare Trust plc is an investment company focused on the healthcare sector. It aims to generate long-term returns by investing in healthcare companies globally.